Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05610267 · ClinicalTrials.gov registry record
Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
A clinical trial of Ventral Hernia, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT05610267 is a study of Ventral Hernia that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 28 participants, below the 141-participant average among 18 other Ventral Hernia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05610267, a study of Ventral Hernia, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.
Conditions Studied
Interventions
- DEVICE Retrospective chart review
Study Locations (1)
Florida
- Surgical Healing Arts Center - Fort Myers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-11-22 |
| Est. Completion | 2022-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05610267
The ClinicalTrials.gov registry entry for NCT05610267 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 18 other Ventral Hernia trials with a reported enrollment target (80% lower). The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Retrospective chart review is the first listed.
NCT05610267 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05610267 about?
NCT05610267 is a clinical study titled "Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair". The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.
What is the current status of trial NCT05610267?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2022-11-22. Estimated completion is 2022-12-28.
What conditions does trial NCT05610267 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT05610267?
The interventions under investigation include: Retrospective chart review (DEVICE).
Who is sponsoring clinical trial NCT05610267?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05610267 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
RECRUITING · Phase 2
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
ACTIVE NOT RECRUITING · Early Phase 1
-
Methocarbamol in Ventral and Inguinal HR
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.